Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Deutsche Boerse AG  >  Pacific Biosciences of California    P09

 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Deutsche Boerse Ag
12/05/2016 12/06/2016 12/07/2016 12/08/2016 12/09/2016 Date
6.352(c) 6.453(c) 6.334(c) 6.439(c) 6.556(c) Last
0 0 300 0 0 Volume
-1.99% +1.59% -1.84% +1.66% +1.82% Change
More quotes
Financials ($)
Sales 2016 87,9 M
EBIT 2016 -73,2 M
Net income 2016 -75,8 M
Debt 2016 15,0 M
Yield 2016 -
Sales 2017 115 M
EBIT 2017 -73,6 M
Net income 2017 -77,0 M
Debt 2017 1,00 M
Yield 2017 -
P/E ratio 2016 -
P/E ratio 2017
EV / Sales2016 7,50x
EV / Sales2017 5,59x
Capitalization 644 M
More Financials
Company
Pacific Biosciences of California, Inc. develops, manufactures and markets sequencing systems to help scientists resolve genetically complex problems.The company has developed a technology to study the synthesis and regulation of DNA combining recent advances in nanofabrication, biochemistry,... 
More about the company
Surperformance© ratings of Pacific Biosciences of Cal
Trading Rating : Investor Rating :
More Ratings
Latest news on PACIFIC BIOSCIENCES OF CAL
12/08 PACIFIC BIOSCIENCES OF CALIFORNIA : Certain Single-Molecule Nucleic Acid Sequenc..
11/04 PACIFIC BIOSCIENCES OF CALIFORNIA : Management's Discussion and Analysis of Fina..
11/03 PACIFIC BIOSCIENCES OF CALIFORNIA : PacBio Files ITC Patent Infringement Complai..
11/02 PACIFIC BIOSCIENCES OF CALIFORNIA : reports 3Q loss
11/02 PACIFIC BIOSCIENCES OF CALIFORNIA, I : Results of Operations and Financial Condi..
11/02 Pacific Biosciences of California, Inc. Announces Third Quarter 2016 Financia..
11/02 PacBio Files ITC Patent Infringement Complaint Against Oxford Nanopore
10/20 PACIFIC BIOSCIENCES OF CALIFORNIA : Patent Issued for Labeled Nucleotide Analogs..
10/17 Novel Human Genetics Discoveries Using PacBio Long-Read Sequencing to be Pres..
10/13 Pacific Biosciences of California, Inc. Third Quarter 2016 Financial Results ..
More news
Sector news : Advanced Medical Equipment & Technology - NEC
12/08 AIXTRON : China's Fujian drops Aixtron bid after Obama blocks deal
12/05 Aixtron could revive takeover despite U.S. block
12/02 Deals scuppered by U.S. regulatory scrutiny
11/29 European spin-offs and carve-outs
11/15 EXCLUSIVE : EU regulators seen clearing $25 billion Abbott, St Jude deal
More sector news : Advanced Medical Equipment & Technology - NEC
Advertisement
Chart PACIFIC BIOSCIENCES OF CAL
Duration : Period :
Pacific Biosciences of Cal Technical Analysis Chart | P09 | US69404D1081 | 4-Traders
Full-screen chart
Income Statement Evolution
More Financials
Consensus 
Mean consensus OUTPERFORM
Number of Analysts 7
Average target price 11,7 $
Spread / Average Target 68%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Mike W. Hunkapiller Executive Chairman, President & CEO
Susan K. Barnes Executive VP, Chief Financial & Accounting Officer
Stephen W. Turner Chief Technology Officer & Vice President
James Michael Phillips Senior Vice President-Research & Development
Jonas Korlach Chief Scientific Officer
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
PACIFIC BIOSCIENCES OF..-45.88%644
THERMO FISHER SCIENTIF..2.51%57 441
DANAHER CORPORATION9.50%54 022
BOSTON SCIENTIFIC CORP..11.77%28 336
PHILIPS18.95%28 064
INTUITIVE SURGICAL, IN..13.42%24 225
More Results